Page last updated: 2024-09-03

desloratadine and Inflammation

desloratadine has been researched along with Inflammation in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J	1
Bryce, PJ; Geha, R; Oettgen, HC	1
Braunstahl, GJ; Fokkens, WJ; Hoogsteden, HC; Kleinjan, A; Overbeek, SE; Reinartz, SM; van Drunen, CM	1
Allen, M; Barberi, S; Ciprandi, G; Cirillo, I; Civardi, E; Marseglia, GL; Vizzaccaro, A	1

Trials

2 trial(s) available for desloratadine and Inflammation

Article	Year
Desloratadine reduces systemic allergic inflammation following nasal provocation in allergic rhinitis and asthma patients. Allergy, 2005, Volume: 60, Issue:10 Topics: Adult; Asthma; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Inflammation; Loratadine; Male; Nasal Provocation Tests; Poaceae; Pollen; Rhinitis, Allergic, Seasonal; Treatment Outcome	2005
Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study. International immunopharmacology, 2005, Volume: 5, Issue:13-14 Topics: Adolescent; Adult; Cetirizine; Double-Blind Method; Eosinophils; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Inflammation; Interleukin-4; Leukocyte Count; Loratadine; Male; Nasal Lavage Fluid; Nasal Mucosa; Nasal Obstruction; Pilot Projects; Piperazines; Rhinitis, Allergic, Perennial; Rhinomanometry	2005

Article

Year

Desloratadine reduces systemic allergic inflammation following nasal provocation in allergic rhinitis and asthma patients.

Allergy, 2005, Volume: 60, Issue:10

Topics: Adult; Asthma; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Inflammation; Loratadine; Male; Nasal Provocation Tests; Poaceae; Pollen; Rhinitis, Allergic, Seasonal; Treatment Outcome

2005

Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.

International immunopharmacology, 2005, Volume: 5, Issue:13-14

Topics: Adolescent; Adult; Cetirizine; Double-Blind Method; Eosinophils; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Inflammation; Interleukin-4; Leukocyte Count; Loratadine; Male; Nasal Lavage Fluid; Nasal Mucosa; Nasal Obstruction; Pilot Projects; Piperazines; Rhinitis, Allergic, Perennial; Rhinomanometry

2005

Other Studies

2 other study(ies) available for desloratadine and Inflammation

Article	Year
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. Current protocols in cytometry, 2010, Volume: Chapter 13 Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature	2010
Desloratadine inhibits allergen-induced airway inflammation and bronchial hyperresponsiveness and alters T-cell responses in murine models of asthma. The Journal of allergy and clinical immunology, 2003, Volume: 112, Issue:1 Topics: Allergens; Animals; Asthma; Bronchial Hyperreactivity; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Histamine H1 Antagonists, Non-Sedating; Immunoglobulin E; Inflammation; Loratadine; Mice; Mice, Inbred BALB C; Ovalbumin; Receptors, Histamine H1; T-Lymphocytes	2003

Article

Year

Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.

Current protocols in cytometry, 2010, Volume: Chapter 13

Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature

2010

Desloratadine inhibits allergen-induced airway inflammation and bronchial hyperresponsiveness and alters T-cell responses in murine models of asthma.

The Journal of allergy and clinical immunology, 2003, Volume: 112, Issue:1

Topics: Allergens; Animals; Asthma; Bronchial Hyperreactivity; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Histamine H1 Antagonists, Non-Sedating; Immunoglobulin E; Inflammation; Loratadine; Mice; Mice, Inbred BALB C; Ovalbumin; Receptors, Histamine H1; T-Lymphocytes

2003